FFG
BEAM icon

Ford Financial Group’s Beam Therapeutics BEAM Stock Holding History

Ford Financial Group’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-135
Closed -$10K – 157
2021
Q4 		$10K Buy
+135
New +$11.6K ﹤0.01% 332
2021
Q3 		– Sell
-135
Closed -$17K – 150
2021
Q2 		$17K Buy
+135
New +$10.8K 0.01% 298

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ford Financial Group's BEAM Position: Q1 2022 in Review

Ford Financial Group sold out of Beam Therapeutics (BEAM) in Q1 2022, closing a stake of 135 shares — an estimated $10K sold.

Ford Financial Group first reported a position in BEAM in Q2 2021 and held it in 2 quarters. The position peaked at $17K in Q2 2021. 240 funds tracked by Wall St. Rank hold BEAM as of Q1 2022.

  • Ford Financial Group reported no remaining Beam Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Ford Financial Group sold 135 Beam Therapeutics shares in Q1 2022, an estimated $10K.
  • Ford Financial Group first reported a position in Beam Therapeutics in Q2 2021 and held it in 2 quarters.
  • Ford Financial Group's Beam Therapeutics position peaked at $17K in Q2 2021.
  • 240 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2022.

Based on Ford Financial Group's 13F filing for Q1 2022, filed 13 Apr 2022.